Cargando…
Emerging role of glucocorticoid receptor in castration resistant prostate cancer: A potential therapeutic target
Glucocorticoids are used as co-medication with chemotherapy for solid tumors to reduce inflammation as well as cytotoxic side effects and are effective in easing symptoms related to chemotherapy. However, emerging evidence suggests that glucocorticoids may contribute to failure of chemotherapy and t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959034/ https://www.ncbi.nlm.nih.gov/pubmed/31942193 http://dx.doi.org/10.7150/jca.32497 |